Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EW3143 / 1||- / -|
Administered by: Other Purchased by: ??
Symptoms: Chills, Fatigue, Headache, Myalgia, Pyrexia
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Other Medications: 5-HTP [OXITRIPTAN]; VITAMIN D 3; IBUPROFEN
Preexisting Conditions: Medical History/Concurrent Conditions: Anxiety; Lactation decreased; Suspected COVID-19
Diagnostic Lab Data:
CDC 'Split Type': GBPFIZER INC2021657925
Write-up: Headache; Chills; Fever; Fatigue; Muscle pain; This is a spontaneous report from a contactable consumer received from the Regulatory Agency (RA). The regulatory authority report number is GB-MHRA-WEBCOVID-202106041921375190-C18AM, Safety Report Unique Identifier GB-MHRA-ADR 25423410. A 32-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 03Jun2021 (Lot Number: EW3143) at single dose at the age of 32 years old for covid-19 immunisation. Medical history included suspected covid-19 from 31Mar2020 to 14Apr2020, lactation decreased from an unknown date, anxiety from an unknown date. No illnesses to report. Patient has not had a COVID-19 test. Patient is not enrolled in clinical trial. Concomitant medications included oxitriptan (5-HTP [OXITRIPTAN])(HEALTHSPAN) taken for anxiety from 20Apr2020 to an unspecified stop date; colecalciferol (VITAMIN D 3) ( oil capsules)taken for an unspecified indication from 01Sep2020 to an unspecified stop date; ibuprofen taken for an unspecified indication, start and stop date were not reported; thiamin, riboflavin, folic acid, vitamin b12, biotin, vitamin k, vitamin b6, calcium, vitamin a, pantothenic acid, vitamin d, vitamin e, zinc, iodine, vitamin c, niacin, iron, magnesium, manganese, copper (SAINSBURYS A-Z MULTIVITAMINS AND MINERALS TABLET) taken for an unspecified indication from 10Dec2020 to an unspecified stop date. The patient experienced fever on 03Jun2021, fatigue on 03Jun2021, muscle pain on 03Jun2021, headache on 04Jun2021, chills on 04Jun2021. The events were serious as medically significant. The clinical course was reported as follows: Al symptoms are currently being managed with a mixed strategy of paracetamol + ibuprofen. Patient has not tested positive for COVID-19 since having the vaccine. The outcome of the events fatigue, muscle pain was not recovered, of the other events was recovering. No follow-up attempts are possible. No further information is expected.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166